SLC40A1 and chronic kidney disease: Indeed, antagonists including PRS-080, NOX-H94 and LY2928057 (a humanized monoclonal FPN antibody) can improve serum iron levels and transferrin saturation in clinical tests with healthy and chronic kidney disease patients [38].